The University of Tokyo Edge Capital

The University of Tokyo Edge Capital is a venture capital firm based in Tokyo, Japan, founded in 2004. It specializes in seed and early-stage investments, focusing on deep-tech sectors including healthcare and life sciences, information technology and artificial intelligence, as well as physical sciences and engineering. UTEC collaborates with academic institutions, notably The University of Tokyo, to identify and support innovative startups. With over $500 million in assets under management, the firm has invested in more than 100 companies across Japan, the United States, Singapore, India, and Europe, achieving a notable track record that includes 13 initial public offerings and 12 successful mergers and acquisitions.

Lenny Chin

Principal

Tomotaka Goji

Managing Partner and President

Maiko Katadae

Partner

Hiroaki Kobayashi

Principal

Kurokawa, Naonori

Partner

Sho Morita

Principal

Okiyama, Tomohiko

Venture Partner

Shimada, Atsushi

Principal

HyungKyu Shin

Associate

Azusa Shiohara

Principal

John Suzuki

Venture Partner

Hiroki Toda Ph.D

Associate

148 past transactions

Violet Therapeutics

Venture Round in 2023
Violet Therapeutics is a pre-clinical stage company leveraging first-in-class platforms to identify, map, and mine the cellular connectome. Violet’s drug discovery programs are focused on CNS diseases enabled by the novel targets elucidated by their platforms. Violet was co-founded by Mass General Brigham Ventures and scientists from Brigham & Women’s Hospital.

Liminal

Series A in 2023
Liminal operates as a battery manufacturing intelligence provider that utilizes data and analytics. Its mission is to make electric vehicles the default option for any driver. The company was founded in 2015 and is headquartered in Emeryville, California.

Oxford Quantum Circuits

Series A in 2022
Oxford Quantum Circuits developing technology using the power of quantum to do things that have never been achieved before, from enabling life-changing drug discoveries to developing new battery technologies. OQC's quantum computer is a fully functional unit that includes the control system, hardware, and software. Customers can use OQC's quantum computers to streamline their businesses, pioneer new approaches, and help solve some of humanity's most pressing issues, such as slowing climate change and feeding a rapidly growing population.

Wassha

Series C in 2022
Wassha provide the rental device and charging service using clean energy. WASSHA lends all devices to start WASSHA business. Remote management and monitoration of every operation made possible with our innovative technology, so that we can check every transactions like sales, customer information, and power generation.We are looking for business partners to expand WASSHA to off-grid areas! s a power supplier for off-grid Africa.

OriCiro Genomics

Series B in 2022
OriCiro Genomics creates a better bioeconomy with innovative genome technologies. The company is a pioneer in cell-free synthesis and amplification of genome-scale large DNA for synthetic biology. The company creates a technology that covers "DNA assembly" and "circular DNA amplification", allowing to construct large circular DNA molecules without relying on conventional biological cloning.

Eureka Robotics

Seed Round in 2022
Featured in The New York Times, The Guardian, The Economist, and CNN, and empowered by research on AI and robotics from NTU Singapore and MIT (U.S.), Eureka Robotics delivers software and systems to automate tasks requiring High Accuracy and High Agility (HAHA). With offices in Singapore, France, and Vietnam, and distribution partners in China, Japan, and the U.S., Eureka Robotics prides itself on helping clients achieve vastly improved productivity, lower costs, and better safety in precision handling, assembly, inspection, drilling, and other manufacturing tasks in industries such as healthcare, telecom, automotive, photonics, electronics, optical, and aerospace, among others.

Liminal

Series A in 2022
Liminal operates as a battery manufacturing intelligence provider that utilizes data and analytics. Its mission is to make electric vehicles the default option for any driver. The company was founded in 2015 and is headquartered in Emeryville, California.

BUGWORKS Research

Series B in 2022
BUGWORKS is a drug discovery company that aims to discover novel pharmaceutical assets for combating Antimicrobial Resistance (AMR). The company was founded in 2014 and is based in Bangalore, India.

The ePlane Company

Seed Round in 2022
ePlane aims to tackle urban road traffic congestion by introducing innovative flying solutions. Their flagship product aims to provide a safe, sustainable, and affordable flying experience, contributing to a future of urban mobility that is efficient and eco-friendly.

Cellusion

Venture Round in 2022
Cellusion is a regenerative medicine startup from Keio University. The mission of Cellusion is to deliver novel therapies for all bullous keratopathy patients by our iPS cells origin corneal endothelial cells mass culture system.

Forest

Seed Round in 2021
Forest Co., Ltd. operates as an e-commerce aggregator, seeks to identify sustainable, high-quality products and brands that embrace the spirit of Japan and help them grow and enter the global market by using the power of technology.

RICOS

Series A in 2021
RICOS is a tech company that optimizes manufacturing processes using AI, simulation, and high-performance computing technologies. RICOS creates an AI algorithm called IsoGCN that is tailored for use with simulation data, allowing for faster and more interactive design and evaluation. RICOS promotes research and development with the goal of realizing a world in which scientific computing technology, including CAE, can be used at manufacturing sites and people's ideals can be realized instantly.

Charco Neurotech

Seed Round in 2021
Charco Neurotech is a medical technology company that develops non-invasive wearable devices.

Capex

Venture Round in 2021
Capex operates "PATONA," an application that uses artificial intelligence solutions. It develops characters built with the user's personal life and interactions. Capex was founded in 2019 and is headquartered in Tokyo, Japan.

OriCiro Genomics

Series B in 2021
OriCiro Genomics creates a better bioeconomy with innovative genome technologies. The company is a pioneer in cell-free synthesis and amplification of genome-scale large DNA for synthetic biology. The company creates a technology that covers "DNA assembly" and "circular DNA amplification", allowing to construct large circular DNA molecules without relying on conventional biological cloning.

VividQ

Seed Round in 2021
VividQ is bringing about a revolution in digital display and creating the human-machine interface for the next generation of consumer devices. VividQ's computational display technology is creating a future where 3D holographic images are cast into our everyday environment, removing the screens that separate our real and virtual experiences. The company partners with leading original electronics manufacturers (OEMs) to integrate its advanced software and hardware solutions into augmented reality (AR), virtual reality (VR), automotive head-up displays, and other consumer electronics. Founded in 2017, the company is based in Cambridge, U.K., with partners and teams in the U.S. and Japan.

PaylessGate

Seed Round in 2021
PaylessGate is an authentication technology company. Their authentication technology utilizes high speed, high precision position measurement technology to grasp location information and perform personal authentication by connecting bluetooth devices, enabling users to provide personal identification without overlapping identification zones.

EditForce

Series A in 2021
EditForce develops drugs and seeds by using nucleic acid (DNA/RNA) manipulation technologies.

Startbahn

Series B in 2021
Startbahn aims to realize a richer society by providing the technology needed by artists and people involved with art all over the world. We are developing Startbahn Cert., a service that issues blockchain certificates for artworks, and promoting the development of Startrail, a blockchain infrastructure that is the basis for Startbahn Cert. We also run joint projects with other companies.

Obviously AI

Seed Round in 2021
At Obviously AI, our vision is to turn every company into an AI company. We do it by combining the power of No-Code AI and human guided data prep to enable businesses to build custom and accurate AI and LLM models in a matter of days.

DATAFLUCT

Series A in 2021
DATAFLUCT provides data management and machine learning services to help solve corporate and social issues with data science. DATAFLUCT's development efforts are focused on the sustainable algorithm, a method of arriving at optimal solutions that balance environmental, social, customer, and economic value. DATAFLUCT helps companies with the high-speed, high-precision realization of multimodal data utilization that creates value by combining all kinds of data.

ImmunoScape

Venture Round in 2021
ImmunoScape is an immunomics-focused company with a technology platform that allows for immune profiling and characterization of the human immune response at extremely high resolution. The company’s Deep Immunomics platform combines mass cytometry, single cell sequencing, and proprietary computational bioinformatics, data analysis, and visualization tools to provide novel, reproducible immune profiling information. This technology has been utilized across multiple therapeutic areas, especially in oncology and infectious disease, both to better understand immunotherapy safety and efficacy and to identify drug targets.

Obniz

Series A in 2021
Obniz is a technology company that offers a cloud based IoT system that provides real time and bi-directional access to real hardware form the cloud. It allows users to control sensors, actuators, and machines directly through the cloud.

HashPort

Venture Round in 2021
Founded in 2018, HashPort aids new web3 businesses with development and financing via Initial Exchange Offerings (IEOs) and develops crypto-asset products, including digital wallets. Its 2020-established subsidiary, HashPalette, conducted Japan's first approved IEO, developed a unique NFT-specialized blockchain, and runs one of Japan's largest NFT marketplaces. In April 2023, HashPort raised over 1.2 billion yen in a Series C round backed by six underwriters.

SWAT Mobility

Venture Round in 2021
SWAT Mobility’s vehicle-routing technology helps companies, transport operators, and government agencies around the world solve complex transportation challenges. We are the first to run high-capacity vehicle pooling services that are both on-demand and dynamically routed. We also have proven results in helping our clients reduce transportation costs, improve city connectivity, and reduce traffic congestion. Our technology tops the industry's benchmark, Li & Lim, and with our cutting-edge smart mobility optimisation engine, we are future-ready for the world of autonomous vehicles.

Agara

Seed Round in 2021
Agara is an autonomous voice conversation agent designed to handle customer support calls without human assistance. Built for the financial services, consumer products, and retail industries, it helps significantly enhance customer experience and cut support costs.

Metcela

Series B in 2021
Metcela is a clinical-stage biotech startup providing patients with an innovative and alternative treatment option for heart disease. The company's lead asset, MTC001 is a cell therapy based on VCAM-1-positive Cardiac Fibroblast (VCF) that re-established a favorable microenvironment and repaired damaged heart tissues in preclinical studies. Metcela's therapy uses a specific fibroblast cell that is obtained from the patient's heart and instead of replacing them, it repairs the damage by enhancing the cells' ability to heal, providing patients with an effective and reasonably-priced cure for heart failure. It was founded on March 9, 2016, and is headquartered in Kawasaki, Japan.

Capex

Venture Round in 2020
Capex operates "PATONA," an application that uses artificial intelligence solutions. It develops characters built with the user's personal life and interactions. Capex was founded in 2019 and is headquartered in Tokyo, Japan.
Japan Data Science Consortium (JDSC) is an AI company that provides solutions for the medical, education and retail areas. As a professional consulting company, JDSC provides holistic support, from system construction to corporate process transformation to realize real profit impact by leveraging AI technology.

Epigeneron

Series B in 2020
Implementation of drug discovery and drug discovery support services and sales of drug discovery related information Manufacture, sale and import / export of research reagents, diagnostic agents, and chemical industrial chemicals Manufacture, sale and import / export of research equipment Intellectual property transfer business All business incidental or related to the preceding items

BionicM

Series A in 2020
BionicM develops high-performance robot prostheses that enhance mobility for people with disabilities. BionicM has been conducting research on innovative technologies since 2015 at the University of Tokyo's Information Systems Engineering Laboratory (JSK) under the guidance of Professor Inaba and utilizing the world's most advanced robotics research. In 2016, we were adopted by the Japan Science and Technology Agency as part of "Program for Creating STart-ups from Advanced Research and Technology" (START), and in 2018, the company was established as a joint-stock company.

bitBiome

Series B in 2020
bitBiome is a synthetic biology company specializing in enzyme discovery and engineering utilizing sequences from their database, the largest proprietary database of natural microbial sequences sourced primarily from environmental collections and built using our microbial single-cell sequencing platform (bit-MAP). bitBiome offers a range of services from single-cell genomics, database screening and shortlisting, to wet lab evaluation of target sequences and directed evolution campaigns.

Tellus

Series A in 2020
Tellus is a platform that provides actionable health information such as changes in vital signs or activity in real-time to improve eldercare quality and operational efficiency. Tellus uses advanced sensor technology to monitor health completely wirelessly, without the need for wearables. Tellus assists care facilities in understanding baseline health data, alerting them, and allowing them to make the best decisions for their residents during emergencies or to prevent them.

ImmunoScape

Venture Round in 2020
ImmunoScape is an immunomics-focused company with a technology platform that allows for immune profiling and characterization of the human immune response at extremely high resolution. The company’s Deep Immunomics platform combines mass cytometry, single cell sequencing, and proprietary computational bioinformatics, data analysis, and visualization tools to provide novel, reproducible immune profiling information. This technology has been utilized across multiple therapeutic areas, especially in oncology and infectious disease, both to better understand immunotherapy safety and efficacy and to identify drug targets.

Estie

Seed Round in 2020
Estie is a real estate tech company in Japan focused on digital transformation in the commercial real estate market, providing various services including market research. The company offers algorithms for rent estimation and quantitative indicators, assisting clients in making data-driven decisions.

TXP Medical

Series A in 2020
TPX Medical brings innovations to the highly complex medical front to make data-based decision-making natural. The company applies technologies to connect the information that remains at each front and create a foundation for the entire medical industry. TPX Medical's products include NEXTStage ER, a platform that supports both medical record input and research, NSER mobile, a mobile application that allows inputting patient information using voice commands and image OCR, and lastly Self Assessment System that allows the patients to input their own data.

BUGWORKS Research

Series B in 2020
BUGWORKS is a drug discovery company that aims to discover novel pharmaceutical assets for combating Antimicrobial Resistance (AMR). The company was founded in 2014 and is based in Bangalore, India.

Nelumbo

Series A in 2020
Nelumbo is commercializing a new platform of structural materials. The company’s current focus is on developing improved heat exchangers for the HVAC market. Our ability to improve energy performance and minimize corrosion in a single platform unlocks mass market opportunity with potential for significant carbon emission and energy use reductions worldwide.

Tricog Health

Series B in 2020
Tricog Health offers cardiac diagnostic tools to help solve cardiovascular conditions by identifying them in real-time and with accuracy. Tricog's medical-grade AI and intuitive tools improve the cardiac care of patients by solving cardiac care infrastructure, expertise, bandwidth, availability, and efficiency gaps. Tricog is committed to providing virtual cardiac diagnostic tools and services to all healthcare providers, assisting them in making accurate, timely, and consistent diagnoses and providing timely care.

OPALai

Seed Round in 2020
OPALai offers AI-driven digital financial products working on commodities and FX markets for pricing, hedging, and trading.

VividQ

Seed Round in 2019
VividQ is bringing about a revolution in digital display and creating the human-machine interface for the next generation of consumer devices. VividQ's computational display technology is creating a future where 3D holographic images are cast into our everyday environment, removing the screens that separate our real and virtual experiences. The company partners with leading original electronics manufacturers (OEMs) to integrate its advanced software and hardware solutions into augmented reality (AR), virtual reality (VR), automotive head-up displays, and other consumer electronics. Founded in 2017, the company is based in Cambridge, U.K., with partners and teams in the U.S. and Japan.

GORYO Chemical

Venture Round in 2019
GORYO Chemical specializes in sales of functional dyes Contract synthesis of functional dyes and development of diagnostic agents.

SWAT Mobility

Series A in 2019
SWAT Mobility’s vehicle-routing technology helps companies, transport operators, and government agencies around the world solve complex transportation challenges. We are the first to run high-capacity vehicle pooling services that are both on-demand and dynamically routed. We also have proven results in helping our clients reduce transportation costs, improve city connectivity, and reduce traffic congestion. Our technology tops the industry's benchmark, Li & Lim, and with our cutting-edge smart mobility optimisation engine, we are future-ready for the world of autonomous vehicles.

Algal Bio

Venture Round in 2019
Algal Bio is an food tech startup, was established in 2018 based upon 20 years of research results at the University of Tokyo.

Wassha

Series B in 2019
Wassha provide the rental device and charging service using clean energy. WASSHA lends all devices to start WASSHA business. Remote management and monitoration of every operation made possible with our innovative technology, so that we can check every transactions like sales, customer information, and power generation.We are looking for business partners to expand WASSHA to off-grid areas! s a power supplier for off-grid Africa.

Retrieva

Venture Round in 2019
Retrieva is a business information system company that focuses on research, development, and support of software using machine learning.

Adacotech

Venture Round in 2019
Adacotech manufactures and develops systems related to video surveillance and automatic recognition. Adacotech offers a system equipped with an algorithm that realizes a "cost-performance" system that can monitor events to be detected for 24 hours while ensuring real-time performance. Although Adaco Tech's products use AIST's patented technology, the productization itself is conducted in-house, from the source to the API.

Mujin

Venture Round in 2019
Mujin develops intelligent robot controllers that serve as a universal platform for industrial robots. These controllers address the limitations of conventional robots, which struggle with adaptability in dynamic environments due to manufacturer-specific operations and complex setups. Using advanced motion planning technology, Mujin automates heavy, repetitive tasks in logistics and manufacturing, streamlining processes traditionally handled by humans.

OriCiro Genomics

Series A in 2019
OriCiro Genomics creates a better bioeconomy with innovative genome technologies. The company is a pioneer in cell-free synthesis and amplification of genome-scale large DNA for synthetic biology. The company creates a technology that covers "DNA assembly" and "circular DNA amplification", allowing to construct large circular DNA molecules without relying on conventional biological cloning.

Startbahn

Series A in 2019
Startbahn aims to realize a richer society by providing the technology needed by artists and people involved with art all over the world. We are developing Startbahn Cert., a service that issues blockchain certificates for artworks, and promoting the development of Startrail, a blockchain infrastructure that is the basis for Startbahn Cert. We also run joint projects with other companies.

EditForce

Corporate Round in 2019
EditForce develops drugs and seeds by using nucleic acid (DNA/RNA) manipulation technologies.

Estie

Seed Round in 2019
Estie is a real estate tech company in Japan focused on digital transformation in the commercial real estate market, providing various services including market research. The company offers algorithms for rent estimation and quantitative indicators, assisting clients in making data-driven decisions.

BionicM

Seed Round in 2019
BionicM develops high-performance robot prostheses that enhance mobility for people with disabilities. BionicM has been conducting research on innovative technologies since 2015 at the University of Tokyo's Information Systems Engineering Laboratory (JSK) under the guidance of Professor Inaba and utilizing the world's most advanced robotics research. In 2016, we were adopted by the Japan Science and Technology Agency as part of "Program for Creating STart-ups from Advanced Research and Technology" (START), and in 2018, the company was established as a joint-stock company.

PharmaBio

Venture Round in 2019
PharmaBio is a health care company that manufacturing and development company specializing in products such as regenerative medicine, we support GCTP-compliant manufacturing with low risk and cost burden, and provide various services and products that enhance safety and quality.

bitBiome

Seed Round in 2019
bitBiome is a synthetic biology company specializing in enzyme discovery and engineering utilizing sequences from their database, the largest proprietary database of natural microbial sequences sourced primarily from environmental collections and built using our microbial single-cell sequencing platform (bit-MAP). bitBiome offers a range of services from single-cell genomics, database screening and shortlisting, to wet lab evaluation of target sequences and directed evolution campaigns.

Obniz

Seed Round in 2018
Obniz is a technology company that offers a cloud based IoT system that provides real time and bi-directional access to real hardware form the cloud. It allows users to control sensors, actuators, and machines directly through the cloud.

ImmunoScape

Seed Round in 2018
ImmunoScape is an immunomics-focused company with a technology platform that allows for immune profiling and characterization of the human immune response at extremely high resolution. The company’s Deep Immunomics platform combines mass cytometry, single cell sequencing, and proprietary computational bioinformatics, data analysis, and visualization tools to provide novel, reproducible immune profiling information. This technology has been utilized across multiple therapeutic areas, especially in oncology and infectious disease, both to better understand immunotherapy safety and efficacy and to identify drug targets.

SOCIUM

Venture Round in 2018
SOCIUM is an AI-powered drug discovery and development company focused on first-in-class small molecules. The company currently has a development portfolio of over 23 diseases, including oncology and rare diseases. The company replaces multiple steps in the traditional drug discovery process with an in-silico system using our cutting edge algorithm, established a system to identify the drug discovery target in a few months. By taking a systems biology approach using our Augmented intelligence and Machine Learning – instead of hypothesizing the mechanism of a disease and focusing on only a few related compounds, we profile the entire disease by analyzing various OMICS data.

Locix

Series B in 2018
Locix develops solutions to provide spatial and contextual awareness to buildings, homes, and connected devices. The company solutions uniquely capture location, visual, and sensor data and combine them with advanced data analytics to provide spatial awareness and enable actionable insights for automated decision making. It is backed by several venture and strategic investors including ID Ventures, University of Tokyo Edge Capital, Murata Manufacturing, NTT Docomo Ventures, Sumitomo Corporation of Americas, iRobot, Yaskawa Information Systems, Yaskawa Electric, and Acer Ventures. Locix was founded in 2015 and is based in Silicon Valley.

Neural Pocket

Venture Round in 2018
Neural Pocket provides Smart City related services for commercial buildings and urban spaces utilizing AI enabled image recognition technology. The company focuses on business development and co-creation serve its clients. Other applications include solutions for digitalization of factories, warehouses, parking lots and retail stores.

BUGWORKS Research

Series A in 2018
BUGWORKS is a drug discovery company that aims to discover novel pharmaceutical assets for combating Antimicrobial Resistance (AMR). The company was founded in 2014 and is based in Bangalore, India.

AI inside

Venture Round in 2018
AI Inside specializes in software development and artificial intelligence business. The company is driven by a mission to realize the digital transformation of society. AI inside converts all information into digital data and contributes to the digital society with an algorithm.

Nohla Therapeutics

Series B in 2018
Nohla Therapeutics' singular passion is the development of best-in-class ex vivo expanded universal donor cellular therapies to transform the treatment of patients with cancer and other life threatening illnesses. Our products are manufactured and cryopreserved on an ongoing basis allowing for a bank of doses that are available for immediate (on demand) use. This is tremendously advantageous with regards to the ease and timing of treatment, the ability to provide repeated dosing for immune-oncology indications and reduction in patient risk and cost relative to other cell therapies.

Startbahn

Seed Round in 2018
Startbahn aims to realize a richer society by providing the technology needed by artists and people involved with art all over the world. We are developing Startbahn Cert., a service that issues blockchain certificates for artworks, and promoting the development of Startrail, a blockchain infrastructure that is the basis for Startbahn Cert. We also run joint projects with other companies.

Elixirgen Therapeutics

Series A in 2018
Elixirgen Therapeutics is a biotechnology company focused on curing humanity’s ailments through stem cell biology. The company concentrates on regenerative and rejuvenative medicine and deals with research in both basic science and in the application of the technologies it discovers and refines. Elixirgen Therapeutics is located in the Science + Technology Park at Johns Hopkins in Baltimore, an ideal research environment that allows Elixirgen Therapeutics’ scientists to conduct research at state-of-the-art facilities. Elixirgen Therapeutics inherits all the therapy-related assets, including intellectual property, from its parent company, Elixirgen, LLC, which has been in active operation since the beginning of 2012.

Fressets

Corporate Round in 2018
Fressets focuses on cryptocurrency and blockchain tech services. The enterprise wallet management (EWM) system, which is primarily aimed at cryptocurrency exchanges or custodians, is the company's main line of business. Users can use multisig addresses and secure hardware to store secret keys, preventing coin theft by hackers.

MiRTeL

Venture Round in 2018
MiRTeL is a healthcare technology company, offering innovative solutions for early disease detection, personalized healthcare, and research.

Aidemy

Series A in 2018
Aidemy is a web service where users can learn AI programming online. Aidemy offers all-in-one teaching materials as well as a programming execution environment. Aidemy implements cutting-edge technology and offers support from DX human resource development centered on AI to actual operation.

Algal Bio

Pre Seed Round in 2018
Algal Bio is an food tech startup, was established in 2018 based upon 20 years of research results at the University of Tokyo.

SOCIUM

Seed Round in 2018
SOCIUM is an AI-powered drug discovery and development company focused on first-in-class small molecules. The company currently has a development portfolio of over 23 diseases, including oncology and rare diseases. The company replaces multiple steps in the traditional drug discovery process with an in-silico system using our cutting edge algorithm, established a system to identify the drug discovery target in a few months. By taking a systems biology approach using our Augmented intelligence and Machine Learning – instead of hypothesizing the mechanism of a disease and focusing on only a few related compounds, we profile the entire disease by analyzing various OMICS data.

TAGCyx Biotechnologies

Series B in 2018
TagCyx’s scientific team has established its proprietary Xenoligo® technology platform, allowing high functional oligonucletide drug discovery. The Xenoligo® platform utilizes genetic alphabet expansion by unnatural base-pairs to generate customized nucleic acid suited for therapeutic applications.

Epigeneron

Venture Round in 2018
Implementation of drug discovery and drug discovery support services and sales of drug discovery related information Manufacture, sale and import / export of research reagents, diagnostic agents, and chemical industrial chemicals Manufacture, sale and import / export of research equipment Intellectual property transfer business All business incidental or related to the preceding items

Tier IV

Seed Round in 2018
Tier IV is a federated academic startup embracing research and development of intelligent vehicles. Founded in December 2015, Tier IV has led the development of open-source software for self-driving technology, also known as Autoware, and applied it for the proof of concept of last-mile driverless mobility and logistics. Tier IV aspires to achieve “Democratization of Intelligent Vehicles”, where any individuals and organizations can contribute to a grander vision of future intelligent vehicles, leading to a better society in which all the people receive new spatio-temporal values.

Neural Pocket

Seed Round in 2018
Neural Pocket provides Smart City related services for commercial buildings and urban spaces utilizing AI enabled image recognition technology. The company focuses on business development and co-creation serve its clients. Other applications include solutions for digitalization of factories, warehouses, parking lots and retail stores.

FCO Power

Venture Round in 2018
FCO Power is a provider of residential fuel cell systems.

Tricog Health

Series A in 2018
Tricog Health offers cardiac diagnostic tools to help solve cardiovascular conditions by identifying them in real-time and with accuracy. Tricog's medical-grade AI and intuitive tools improve the cardiac care of patients by solving cardiac care infrastructure, expertise, bandwidth, availability, and efficiency gaps. Tricog is committed to providing virtual cardiac diagnostic tools and services to all healthcare providers, assisting them in making accurate, timely, and consistent diagnoses and providing timely care.
ACSL is an industrial drone manufacturer and solution provider in Japan originated from the laboratory of Professor Kenzo Nonami at Chiba University since 1998. ACSL is engaged in the R&D, manufacturing, sales and building solutions for industrial drone applications. With its proprietary technologies made and developed in Japan, ACSL aims to lead to the new industrial revolution of the global skies.

PharmaBio

Venture Round in 2018
PharmaBio is a health care company that manufacturing and development company specializing in products such as regenerative medicine, we support GCTP-compliant manufacturing with low risk and cost burden, and provide various services and products that enhance safety and quality.

Provigate

Seed Round in 2017
PROVIGATE is a provider of bio-transistor sensor technologies in Japan.The company's technologies are able to measure dynamic changes with the help of perception-broadening sensors, enabling individuals to change their habits for health
ACSL is an industrial drone manufacturer and solution provider in Japan originated from the laboratory of Professor Kenzo Nonami at Chiba University since 1998. ACSL is engaged in the R&D, manufacturing, sales and building solutions for industrial drone applications. With its proprietary technologies made and developed in Japan, ACSL aims to lead to the new industrial revolution of the global skies.

Aidemy

Seed Round in 2017
Aidemy is a web service where users can learn AI programming online. Aidemy offers all-in-one teaching materials as well as a programming execution environment. Aidemy implements cutting-edge technology and offers support from DX human resource development centered on AI to actual operation.

Institution for a Global Society

Corporate Round in 2017
Institution for a Global Society provides education institutions and businesses with innovative, seamless, and bias-less assessment solutions. The company's solutions include GROW Academy, DxGROW, Ai GROW, and GROW360. The company uses appropriate technology ethically to create a society where everyone can sustainably learn and develop over the course of a lifetime.

Repertoire Genesis

Series C in 2017
Repertoire Genesis supports the realization of new diagnostic methods / therapeutic methods related to personalized medicine by utilizing T cell / B cell receptor retort analysis and neo-epithelial analysis.

FLOSFIA

Venture Round in 2017
FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.

NS Materials

Venture Round in 2017
NS Materials is a developer of micro-space chemical technologies. The company specializes in the development of nano-phosphor for LED lighting and chemical synthesis technologies.

Retrieva

Venture Round in 2017
Retrieva is a business information system company that focuses on research, development, and support of software using machine learning.

Routrek Networks

Venture Round in 2016
Routrek Networks advances IoT to support sustainable farming, tackling food issues with AI irrigation and network control.

Wassha

Series A in 2016
Wassha provide the rental device and charging service using clean energy. WASSHA lends all devices to start WASSHA business. Remote management and monitoration of every operation made possible with our innovative technology, so that we can check every transactions like sales, customer information, and power generation.We are looking for business partners to expand WASSHA to off-grid areas! s a power supplier for off-grid Africa.

GORYO Chemical

Venture Round in 2016
GORYO Chemical specializes in sales of functional dyes Contract synthesis of functional dyes and development of diagnostic agents.

Institution for a Global Society

Venture Round in 2016
Institution for a Global Society provides education institutions and businesses with innovative, seamless, and bias-less assessment solutions. The company's solutions include GROW Academy, DxGROW, Ai GROW, and GROW360. The company uses appropriate technology ethically to create a society where everyone can sustainably learn and develop over the course of a lifetime.

SEAOS

Venture Round in 2016
SEAOS is a business consulting company that offers logistics strategy, product licensing application software, and robot development.

TAGCyx Biotechnologies

Venture Round in 2016
TagCyx’s scientific team has established its proprietary Xenoligo® technology platform, allowing high functional oligonucletide drug discovery. The Xenoligo® platform utilizes genetic alphabet expansion by unnatural base-pairs to generate customized nucleic acid suited for therapeutic applications.

Repertoire Genesis

Series B in 2016
Repertoire Genesis supports the realization of new diagnostic methods / therapeutic methods related to personalized medicine by utilizing T cell / B cell receptor retort analysis and neo-epithelial analysis.

MiRTeL

Venture Round in 2016
MiRTeL is a healthcare technology company, offering innovative solutions for early disease detection, personalized healthcare, and research.

ZenmuTech

Seed Round in 2016
ZenmuTech is a provider of security solutions intended to protect important information from leakage and theft. The company's platform provides security solutions implemented with conventional encryption technology by converting information into dispersing information bits based on secret sharing technologies, thereby enabling organizations to protect themselves from security threats.

Exergy Power Systems

Corporate Round in 2016
Exergy Power Systems is focused on developing, producing, and providing energy storage systems that make use of its uniquely developed hydrogen cells, which have ultrafast charging and discharging properties, as well as enhanced durability.
ACSL is an industrial drone manufacturer and solution provider in Japan originated from the laboratory of Professor Kenzo Nonami at Chiba University since 1998. ACSL is engaged in the R&D, manufacturing, sales and building solutions for industrial drone applications. With its proprietary technologies made and developed in Japan, ACSL aims to lead to the new industrial revolution of the global skies.

ReasonWhy

Series A in 2016
ReasonWhy develops healthcare IT services. The company operates three main services: Whytlink, a social network for doctors; Findme, an online second-opinion service that connects doctors in Whytlink to patients; WhytPlot, a big-data analysis tool for pharmaceutical manufacturers in Japan; and yourHospital, a search engine for specialist hospitals.

EditForce

Corporate Round in 2016
EditForce develops drugs and seeds by using nucleic acid (DNA/RNA) manipulation technologies.

Liquid

Seed Round in 2015
Liquid, Inc. is a Tokyo-based company founded in 2013 that specializes in the manufacture and development of biometric authentication technology. The company creates fingerprint sensing and payment devices, along with associated software. Its products utilize advanced authentication algorithms and image analysis technology, allowing users to register payment methods, such as point cards or credit cards, linked to their fingerprint information. This innovative approach enables customers to make payments conveniently and securely using their fingerprints, streamlining the transaction process. Liquid's focus on biometric identity verification positions it at the forefront of the evolving payment industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.